Opendata, web and dolomites

PLASREVOLUTION SIGNED

Understanding the evolution of plasmid-mediated antibiotic resistance in real life scenarios

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLASREVOLUTION project word cloud

Explore the words cloud of the PLASREVOLUTION project. It provides you a very rough idea of what is the project "PLASREVOLUTION" about.

superbugs    life    transmission    exploring    patients    time    plasmid    society    successful    tools    patient    alleviated    pivotal    treatment    obj    meeting    plan    chemotherapy    uncontrollably    compensatory    indispensable    molecular    antibiotic    bacteria    entail    resolution    bacterial    plasmids    hospitalized    associations    basis    clinically    host    infectious    clones    medicine    breaking    constricted    settings    arrive    despite    resistance    horizontal    avenues    genes    transfer    bacterium    dawn    gap    spread    inappropriate    clinical    extensive    bridge    treatments    mainly    gut    fuelled    fitness    post    mechanisms    central    microbiome    interventions    diseases    contexts    evolution    drive    unprecedentedly    pathogenic    play    completely    scenarios    dynamic    subsequently    clone    underlying    opening    first    conjugation    cancer    ground    modern    coevolution    mediated    compensation    ar    genetic    dynamics    unexplored    antibiotics    era    surgery   

Project "PLASREVOLUTION" data sheet

The following table provides information about the project.

Coordinator
SERVICIO MADRILENO DE SALUD 

Organization address
address: PLAZA CARLOS TRIAS BERTRAN 7
city: MADRID
postcode: 28020
website: http://cort.as/10Yf

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 1˙497˙314 €
 EC max contribution 1˙497˙314 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERVICIO MADRILENO DE SALUD ES (MADRID) coordinator 1˙497˙314.00

Map

 Project objective

Antibiotics are essential tools in modern medicine and are indispensable not only for the treatment of infectious diseases but also to support other key interventions such as surgery and cancer chemotherapy. However, the extensive and inappropriate use of antibiotics has fuelled the spread of resistance mechanisms in pathogenic bacteria, leading to the dawn of a post-antibiotic era. Plasmids play a pivotal role in the evolution of antibiotic resistance (AR) because they drive the horizontal transfer of resistance genes between pathogenic bacteria by conjugation. Some of these plasmid-bacterium associations become particularly successful, creating superbugs that spread uncontrollably in clinical settings. The rise of these clones is mainly constricted because plasmids entail a fitness cost when they arrive in a new bacterial host. This cost can be subsequently alleviated through compensatory adaptation during plasmid-bacterium coevolution. Despite the importance of this cost-compensation dynamic in the evolution of plasmid-mediated AR, it remains completely unexplored in clinical contexts. In this project I plan to bridge this gap by exploring the genetic basis underlying the evolution of plasmid-mediated AR in clinically relevant scenarios. We will study, for the first time, the intra-patient transmission, fitness cost and adaptation of AR plasmids in the gut microbiome of hospitalized patients (obj. 1). We will analyse the molecular mechanisms that determine the success of AR plasmids and bacterial clone associations (obj. 2). Finally, we will develop new technology to test how antibiotic treatments affect AR plasmids dynamics in the gut microbiome at an unprecedentedly high-resolution (obj. 3). This ground-breaking project will allow a new understanding of the evolution of plasmid-mediated AR in real life, opening new research avenues and providing a major step towards meeting one of the central challenges facing our society: controlling the spread of AR.

 Publications

year authors and title journal last update
List of publications.
2019 R. Craig MacLean, Alvaro San Millan
The evolution of antibiotic resistance
published pages: 1082-1083, ISSN: 0036-8075, DOI: 10.1126/science.aax3879
Science 365/6458 2019-10-03
2018 Alvaro San Millan
Evolution of Plasmid-Mediated Antibiotic Resistance in the Clinical Context
published pages: , ISSN: 0966-842X, DOI: 10.1016/j.tim.2018.06.007
Trends in Microbiology monthly 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLASREVOLUTION" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLASREVOLUTION" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

CoolNanoDrop (2019)

Self-Emulsification Route to NanoEmulsions by Cooling of Industrially Relevant Compounds

Read More  

QUAMAP (2019)

Quasiconformal Methods in Analysis and Applications

Read More  

OAlipotherapy (2018)

Long-retention liposomic drug-delivery for intra-articular osteoarthritis therapy

Read More